Finance

Beta
Lists
RHCGF:OTCMKTS
Ryman Healthcare Ltd
$1.41
0.00%
(0.00) 1D
Feb 2, 2:25:57 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RHCGF...
Mkt. cap
2.33B
Avg. vol.
0.00
Volume
0.00
52-wk high
$1.75
52-wk low
$1.41
Beta
1.10
Shares outstanding
1.02B
No. of employees
8K
Mkt. cap
2.33B
Avg. vol.
0.00
Volume
0.00
52-wk high
$1.75
52-wk low
$1.41
Beta
1.10
Shares outstanding
1.02B
No. of employees
8K
News stories
From sources across the web
Profile
Ryman Healthcare Limited is a New Zealand retirement village and rest home operator. It is listed on the New Zealand Stock Exchange and was one of the largest companies listed on the NZX 50 Index. Ryman Healthcare has 48 operational villages across New Zealand and eight in Melbourne, and is developing further villages in New Zealand and Victoria. Its name is a portmanteau of its two founders, John Ryder and Kevin Hickman, who founded the company in 1984. As at June 2024, Ryman Healthcare has a market capitalisation of over $2.6 Billion NZD. Ryman's business model is a mixture of property development and healthcare services. It operates on a "deferred management fees" model where the village resident pays for a lifetime occupancy use of their apartment or unit, and upon moving out, the resident or their estate receives a lesser sum back for their unit, capped at 20% deducted if over a five-year period. Ryman Healthcare villages offer a blend of different retirement living options at their villages, which are usually large enough to support a mini-hospital for residents and a secure dementia wing. Wikipedia
About Ryman Healthcare Ltd
CEO-
Employees7.8K
Founded1984
Headquarters-
SectorHealth care provider
Websiterymanhealthcare.co.nz
Previous reportsAll values in NZD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NZD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
206.73M
206.73M
220.50M
220.50M
Cost of goods sold
188.46M
188.46M
198.38M
198.38M
Cost of revenue
188.46M
188.46M
198.38M
198.38M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
10.91M
10.91M
10.37M
10.37M
Total operating expenses
199.37M
199.37M
208.75M
208.75M
Operating income
7.36M
7.36M
11.75M
11.75M
Other non operating income
-
-
3.63M
3.63M
EBT including unusual items
-20.10M
-20.10M
-68.71M
-68.71M
EBT excluding unusual items
-20.50M
-20.50M
-18.06M
-18.06M
Income tax expense
2.50M
2.50M
-5.63M
-5.63M
Effective tax rate
-12.44%
-12.44%
8.20%
8.20%
Other operating expenses
-
-
-
-
Net income
-22.60M
-22.60M
-63.08M
-63.08M
Net profit margin
-10.93%
-10.93%
-28.61%
-28.61%
Earnings per share
-
-
-
-
Interest and investment income
156.00K
156.00K
403.50K
403.50K
Interest expense
-28.02M
-28.02M
-33.84M
-33.84M
Net interest expenses
-27.87M
-27.87M
-33.43M
-33.43M
Depreciation and amortization charges
10.91M
10.91M
10.37M
10.37M
EBITDA
18.27M
18.27M
20.69M
20.69M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer